Viral Conjunctivitis Treatment Study

Status Terminated

Clinical Trial Summary

The objective of this study is to determine the efficacy Avenova® (0.01% hypochlorous acid) in the treatment of viral conjunctivitis. The investigators hypothesize that patients treated with Avenova® will have a quicker resolution of their ocular signs and symptoms of Viral Conjunctivitis compared with artificial tears.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03861728
Study type	Interventional
Source	University of Miami
Contact
Status	Terminated
Phase	N/A
Start date	November 14, 2018
Completion date	February 8, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03055065` - ADenoVirus Initiative Study in Epidemiology in Italy	N/A
Completed	`NCT01977443` - Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)	Phase 2
Completed	`NCT02054234` - ADenoVirus Initiative Study in Epidemiology in France	N/A
Completed	`NCT02254330` - ADenoVirus Initiative Study in Epidemiology in Spain	N/A
Completed	`NCT01179412` - Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine	Phase 4
Completed	`NCT02112773` - ADenoVirus Initiative Study in Epidemiology in UK	N/A
Completed	`NCT01481519` - A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis	Phase 3
Completed	`NCT02054273` - ADenoVirus Initiative Study in Epidemiology in Germany	N/A